Press Releases Biomm S.A.

Equities

BIOM3

BRBIOMACNOR2

Delayed Sao Paulo Other stock markets 10:36:31 2024-05-17 EDT			5-day change	1st Jan Change
15.97 ^BRL	-2.38%		-11.28%	+176.30%

04-18	Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil	MT
04-17	Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomm S A : Webcast Presentation 3Q23	11-14	PU
Biomm S A : Apresentação de resultados 2T23	23-08-09	PU
Biomm S A : Presentation of 1Q22 Results	22-05-15	PU
Biomm S A : Comunicado ao Mercado	22-03-03	PU
CytoDyn : Receives Clearance from Brazil's FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)	21-09-23	AQ
CytoDyn : Receives Clearance from Brazil's ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients	21-08-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW